Trial Profile

A phase 2 proof-of-concept placebo-controlled, randomized, parallel group study of AER-901 in patients with either pulmonary hypertension associated with interstitial lung disease (PH-ILD) and pulmonary arterial hypertension (PAH)

Status: Not yet recruiting

Phase of Trial: Phase II

Latest Information Update: 25 Jun 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

22 May 2024 Trial design presented at the 120th International Conference of the American Thoracic Society
22 May 2024 Status changed from planning to not yet recruiting as per trial design presented at the 120th International Conference of the American Thoracic Society
20 May 2024 According to an Aerami Therapeutics media release, the trial design of this trial presented at the American Thoracic Society (ATS) 2024 International Conference

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com